Où se trouve le siège social de Jamp Pharma?

Jamp Pharma a son siège social à Boucherville, sur la Rive-Sud de Montréal, et exploite des installations de fabrication et de distribution au Québec.

Quels types de produits Jamp Pharma commercialise-t-elle?

Jamp Pharma commercialise plus de 600 produits, dont des médicaments génériques d'ordonnance, des produits en vente libre, des vitamines, des suppléments et des produits institutionnels.

Jamp Pharma est-elle conforme à Santé Canada?

Oui. Tous les produits Jamp Pharma sont approuvés par Santé Canada et fabriqués selon les Bonnes Pratiques de Fabrication (BPF) reconnues.

Jamp Pharma — Jamp Pharma est l'un des plus importants fabricants pharmaceutiques canadiens in

About

Founded in Quebec, Jamp Pharma has grown in two decades into one of the leading independent Canadian pharmaceutical players. Its headquarters is located in Boucherville on Montreal's South Shore, bringing together strategic, regulatory, commercial, quality and logistics functions. The portfolio spans more than 600 products marketed in Canada: prescription generics in roughly twenty therapeutic areas, over-the-counter medicines for pain, cold, allergies, digestive health and dermatology, a broad range of vitamins, minerals and natural health products (notably through Orimed and Wampole), and sterile injectable solutions for the institutional market. On the industrial side, Jamp Pharma relies on a hybrid model combining internal manufacturing, partnerships with certified manufacturers and strategic acquisitions that continually expand its offering. Products comply with Health Canada requirements, Good Manufacturing Practices and applicable ISO standards, with a diversified supply chain to minimize shortage risks. Markets served include independent pharmacies, major retail banners, hospitals, group purchasing organizations, medical clinics and long-term care facilities across Canada. For these customers, Jamp Pharma acts as a strategic partner offering breadth of portfolio, supply reliability, regulatory support and economic competitiveness, with the proximity of a well-established Quebec-based partner — a meaningful asset for buyers focused on continuity and value.

Products

Médicaments génériques d'ordonnance

Portefeuille de plus de 600 médicaments génériques distribués au Canada.

Jamp Pharma's prescription generics portfolio includes more than 600 products, covering roughly twenty therapeutic areas: cardiovascular, metabolic (diabetes, dyslipidemia), central nervous system (mental health, pain), gastroenterology, respiratory, anti-infectives, dermatology, urology and more. Each product is marketed under a Health Canada-approved DIN. Manufacturing relies on a hybrid model combining internal facilities and partnerships with GMP-certified manufacturers. Quality control covers raw materials, in-process production stages and finished products, with identity, assay, dissolution and stability testing aligned with applicable pharmacopeias. These medicines are distributed through retail pharmacies (independents and major banners), hospitals, clinics, group purchasing organizations and long-term care facilities across Canada. For buyers and pharmacists, benefits include: a broad catalog covering most therapeutic classes, strong economic value versus branded products, supply reliability strengthened by a diversified supply chain, and structured customer service to manage orders, recalls and regulatory notices — making Jamp a dependable partner for generic procurement in the Canadian market.

Produits en vente libre (OTC)

Gamme OTC pour douleur, rhume, allergies et santé digestive.

Jamp Pharma's over-the-counter (OTC) portfolio covers the main categories of Canadian self-care: analgesics (acetaminophen, ibuprofen, ASA), cold and flu remedies, allergy antihistamines, digestive health products (antacids, laxatives, antidiarrheals), dermatological products and assorted care items. These products are manufactured under Good Manufacturing Practices, approved by Health Canada (DIN or NPN depending on the category), with rigorous quality control covering raw materials, formulation and finished product. Packaging meets regulatory requirements for bilingual labeling and contraindication compliance. The Jamp OTC range primarily serves retail pharmacies (independents and major banners), as well as mass merchandisers, convenience stores and specialty distributors. Products are available under the Jamp brand and, in some cases, as private label for retailers. Benefits include: competitive pricing versus national brands, broad category coverage, full regulatory compliance, marketing support for retailers and reliable pan-Canadian logistics. For pharmacists, these products offer a quality, value-priced alternative to recommend to patients in self-care — a meaningful lever for category margin and patient affordability.

Vitamines et suppléments Orimed

Produits de santé naturels, vitamines et minéraux pour pharmacies canadiennes.

The Orimed vitamins and supplements range, integrated into Jamp Pharma's portfolio through acquisition, brings together natural health products well recognized in Canada: multivitamins, single vitamins (D, C, B12, etc.), minerals (iron, magnesium, calcium, zinc), omega-3s, probiotics and specialized formulations (bone, immune, women's, men's health). All products comply with the Canadian Natural Health Product Regulations (NPN) and are manufactured under applicable Good Manufacturing Practices. Formulations rely on proven doses and quality ingredients, with identity, purity and stability controls. The range is primarily distributed through Canadian retail pharmacies, in the natural health section. It is also present in selected specialty channels and as private label for retail partners. Benefits include: a brand well recognized by pharmacists, strong value for money, broad coverage of natural-health needs, support from a dedicated scientific and marketing team, and alignment with pharmacy category rotation. For retailers, Orimed offers an integrated solution to structure the vitamins-and-supplements category in store — supporting both shopper trust and category margin.

Produits hospitaliers injectables

Solutions injectables et formulations stériles pour le marché institutionnel.

Jamp Pharma's hospital injectable portfolio targets the needs of hospitals, oncology centers, critical-care clinics and long-term care facilities. It includes sterile solutions and generic injectables in essential therapeutic classes (anti-infectives, analgesics, anesthetics, antiemetics, cardiovascular, etc.) in line with approved labeling. Manufacturing relies on GMP-certified partners for sterile injectable dosage forms, with strict quality control of raw materials, aseptic processes, sterility and pyrogenicity testing and stability studies aligned with Canadian requirements. These products are distributed to hospitals and group purchasing organizations through Jamp Pharma's pan-Canadian logistics network, with dedicated service for institutional tenders and group contracts. Benefits include: expanded generic alternatives for hospitals, supply reliability in critical classes regularly under shortage pressure, full regulatory support, lot traceability and personalized support for hospital pharmacy departments. For institutional buyers, Jamp Pharma acts as a credible and cost-effective Canadian source for essential medicines — a meaningful contribution to drug-supply resilience.

Services

Distribution pharmaceutique nationale

Réseau de distribution couvrant pharmacies, hôpitaux et chaînes au Canada.

Jamp Pharma operates a pan-Canadian pharmaceutical distribution network that delivers its 600+ products to pharmacies, hospitals, clinics and long-term care facilities across every province. Logistics combine regional warehouses, partnerships with specialty distributors and rapid-delivery capacity to meet the strict requirements of the healthcare sector. The process covers order management (B2B and institutional), respect of storage conditions (temperature control for select categories), lot traceability, compliance with regulatory requirements (recalls, notices, certifications) and coordination with group purchasing organizations. Customers served include independent pharmacies, major retail banners, pharmacy chains, hospital groups, oncology centers and long-term care facilities. Service also includes customer support for technical and regulatory questions. Benefits include: pan-Canadian coverage, reliable lead times, full traceability, rapid response to Health Canada recalls or notices, integration with the main pharmacy order systems and bilingual customer service. For buyers, Jamp Pharma offers the rare combination of catalog breadth and reliable logistics execution at national scale — a meaningful efficiency lever for procurement teams.

Affaires réglementaires et soumissions Santé Canada

Préparation et dépôt des dossiers réglementaires pour produits génériques et OTC.

Jamp Pharma maintains an in-house regulatory affairs team that drives all Health Canada submissions for its prescription generics, over-the-counter products, natural health products and hospital solutions. This expertise is a pillar of the company's sustained portfolio growth. The process covers preparation of abbreviated new drug submissions (ANDS), DIN applications, natural health product licenses (NPN), regulatory supplements, post-approval changes, pharmacovigilance reports and establishment license renewals. Submissions follow Health Canada requirements, ICH guidelines and applicable pharmacopeias. This expertise primarily serves Jamp Pharma's internal operations but also supports licensing partnerships, acquisitions and third-party manufacturing agreements. The team works closely with quality, production, marketing and legal departments. Benefits include: well-managed new-product launch cycles, continuous regulatory compliance, proactive pharmacovigilance management, rapid response to regulatory change, and strategic support to future acquisitions. This internal capability is a key driver of how quickly Jamp Pharma enriches its Canadian offering year after year — a meaningful competitive advantage in a regulated market.